Skip to main content
The Egyptian Journal of Neurology, Psychiatry and Neurosurgery

Table 1 Other studies with history of asthma, eosinophilia and no improvement after IVIg were the clues towards the vasculitic neuropathy, and it was supported by ANCA positivity in majority of cases

From: Eosinophilic granulomatosis with polyangiitis (Churg–Strauss syndrome) imitating Guillain–Barre syndrome (GBS): a case report

  Study Age Presentation Lab findings NCS Other Treatment Outcome
1 Ng et al. (1997) 58/M Symmetric weakness, hyporeflexia, asthma Eosinophilia, raised ESR, P-ANCA + ve Mixed demyelinating polyneuropathy, multifocal absent F waves Lung infiltrates Steroids, cyclophosphamide, plasma exchange Expired
2 Kevent et al. (1998) 57/M Symmetric weakness, hyporeflexia Raised ESR, P-ANCA + ve Mixed demyelinating polyneuropathy, multifocal absent F waves Nephritis Steroids Improved
3 Riva et al. (2008) 51/F Asthma, nasal polyposis, symmetric weakness, hyporeflexia Eosinophilia, raised ESR, P-ANCA -ve Motor asymmetric axonal polyneuropathy, multifocal absent F waves   IVIg, steroids Improved
4 Djukic et al. (2008) 74/M Asthma, symmetric weakness, hyporeflexia Eosinophilia Mixed demyelinating polyneuropathy, multifocal absent F waves   Steroids, cyclophosphamide Improved
5 Lemarroy et al. (2015) 36/F Asthma, pansinusitis, purpura, symmetric weakness, hyporeflexia Eosinophilia, raised ESR, P-ANCA + ve Motor asymmetric axonal polyneuropathy   Steroids, cyclophosphamide Improved
6 Bortolani et al. (2016) 68/F Asthma, symmetric weakness, areflexia Eosinophilia, P-ANCA + ve Motor axonal polyneuropathy   Steroids Improved
7 Yadav et al. (2017) 57/F Asthma, symmetric weakness, hyporeflexia Eosinophilia, proteinuria, P-ANCA + ve Severe axonal and demyelinating polyneuropathy Nephritis Steroids, cyclophosphamide Improved
8 Kim et al. (2018) 51/F Asthma, asymmetric weakness, hyporeflexia, purpura Eosinophilia, maxillary sinusitis, P-ANCA + ve Sensory, motor, axonal, polyneuropathy   Steroids Improved
  1. ESR erythrocyte sedimentation rate, P-ANCA perinuclear antineutrophil cytoplasmic antibodies, IVIg intravenous immunoglobulin
Back to article page